Company news March 23 2023

BriSTAR Immunotech to Present its Novel Cell Therapy for Acute Myeloid Leukemia at the 2023 AACR Annual Meeting

Company news January 31 2023

BriSTAR Immunotech to Present at the BIO CEO & Investor Conference

Company news January 19, 2023

BriSTAR Immunotech To Present its Novel Cell Therapy for Acute Myeloid Leukemia at the AACR Special Conference on AML and MDS

Company news 2022-09-19

BriSTAR Immunotech Announces the Addition of Dr. Christopher J. Paige as a Member of the Company's Scientific Advisory Board

Company news 2022-06-15

Bristar Immunotech Limited wins the KPMG China "First Top 50 Biotechnology Innovation Enterprises" Award 2022

Company news 2022-05-16

Bristar Immunotech Limited, along with the clinical team of Ludaopei Hospital and the scientific research group of Tsinghua University, publishes the research results of CD19 STAR-T in the world-class hematology journal

Company news 2021-12-22

Bristar Immunotech Limited wins the title of "Top 100 Chinese Pharmaceutical Innovation Enterprises 2021"

Company news 2021-11-10

Bristar Immunotech Limited will announce the latest clinical data on CMV TCR-T at the 63rd annual meeting of the American Society of Hematology (ASH)

Company news 2021-10-13

Professor Lin Xin, the founder of Bristar Immunotech Limited, is invited to attend the IGC Forum 2021, and delivers a special report on the conference

Company news 2021-10-11

Bristar Immunotech Limited completed the round B financing of more than 200 million Yuan: Accelerating the Development of Innovative Cell Therapy Drugs for Meeting the Clinical Needs of the Patients with Advanced Cancer

Company news 2021-06-17

Eha2021丨 Bristar Immunotech Limited releases the latest data on CD19/CD20 Dual STAR-T Therapy R/R B-ALL

Company news 2021-04-07

Tsinghua University Team develops engineering immune cell STAR-T, and the first clinical application of dual-target therapy related to the platform will be submitted soon - an exclusive interview with Bristar Immunotech Limited

Company news 2021-04-06

Lin Xin's comments | A new weapon to overcome solid tumors - STAR-T

Company news 2021-02-08

[Cover story of ASH 2020] Bristar Immunotech Limited's innovative STAR-T is reported at the headlines of the Hematology News, the official journal of the American Society of Hematology